Update on Diabetic Disease

• by Diana V. Do, MD

• May 1, 2026

Investigational OCTA Devices Show Promise in Diabetic Disease Assessment

At Retina World Congress, Patricio G. Schlottmann, MD, discussed investigational widefield OCTA platforms made by Chinese company TowardPi Medical.

• by Patricio G. Schlottmann, MD, Patricio G. Schlottmann, MD

• May 14, 2026

• 2 min

Meta-analysis of the association between retinopathy and the risk of stroke

• by Lingyun Wu, Weifeng Jiang

• June 30, 2026

DME AWARE Study Defines Key Needs

Presenting results from the DME AWARE Delphi Study at the Association for Research in Vision and Ophthalmology (ARVO) meeting in Denver, Baruch D. Kuppermann, MD, PhD, director of the Gavin Herbert Eye Institute at the University of California, Irvine, described a set of consensus findings that point to unmet needs across the continuum of DME management, with particular emphasis on early intervention and noninvasive treatment options (Figure 1).

• by Jim Gallagher, senior managing editor

• May 1, 2026

• 5 min